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Abstract
Barrett’s oesophagus is a premalignant metaplastic condition that predisposes patients to
the development of oesophageal adenocarcinoma. However, only a minor fraction of Bar-
rett’s oesophagus patients progress to adenocarcinoma and it is thus essential to determine
bio-molecular markers that can predict the progression of this condition. Telomere dysfunc-
tion is considered to drive clonal evolution in several tumour types and telomere length anal-
ysis provides clinically relevant prognostic and predictive information. The aim of this work
was to use high-resolution telomere analysis to examine telomere dynamics in Barrett’s
oesophagus. Telomere length analysis of XpYp, 17p, 11q and 9p, chromosome arms that
contain key cancer related genes that are known to be subjected to copy number changes in
Barrett’s metaplasia, revealed similar profiles at each chromosome end, indicating that no
one specific telomere is likely to suffer preferential telomere erosion. Analysis of patient
matched tissues (233 samples from 32 patients) sampled from normal squamous oesopha-
gus, Z-line, and 2 cm intervals within Barrett’s metaplasia, plus oesophago-gastric junction,
gastric body and antrum, revealed extensive telomere erosion in Barrett’s metaplasia to
within the length ranges at which telomere fusion is detected in other tumour types. Telo-
mere erosion was not uniform, with distinct zones displaying more extensive erosion and
more homogenous telomere length profiles. These data are consistent with an extensive
proliferative history of cells within Barrett’s metaplasia and are indicative of localised clonal
growth. The extent of telomere erosion highlights the potential of telomere dysfunction to
drive genome instability and clonal evolution in Barrett’s metaplasia.
Introduction
Barrett’s oesophagus is an acquired, hyper-proliferative and premalignant lesion that arises
as a result of prolonged chronic gastroesophageal reflux disease. It leads to the metaplastic
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replacement of the squamous lining of the lower oesophagus by columnar intestinal-like epi-
thelium and goblet cells [1, 2] and predisposes to the development of oesophageal adenocarci-
noma [3, 4]. Barrett’s oesophagus is characterised by genetic heterogeneity; including large-
scale copy number changes across the genome, with key loss of heterozygosity (LOH) events at
9p (involving the CDKN2A locus) and 17p (the TP53 locus) that facilitate progression [5, 6].
The loss of TP53 is also considered permissive for the subsequent development of aneuploidy
and tetraploidy [7]. This genetic heterogeneity provides the diversity upon which clonal selec-
tion can operate and drive progression to adenocarcinoma [8]. The mechanisms that underpin
the genetic heterogeneity observed in Barrett’s oesophagus have not been formally identified.
Telomere dysfunction and resulting fusion events are a key mechanism that can drive large-
scale genomic instability and clonal evolution in many tumour types [9, 10]. Human telomeres
consist of arrays of TTAGGG repeats, which together with the multi-protein complex “shel-
terin”, cap the ends of the chromosome termini and distinguish the natural chromosome end
from internal double-stranded DNA breaks [11]. Telomerase, a reverse transcriptase, maintains
telomeres in the germ-line, in some stem cells and 85% of tumours, but is undetectable in most
normal somatic tissues [12, 13]. As a consequence, telomeres in normal cells exhibit a progres-
sive decline in telomere length as a function of cell division. Subsequently, telomere erosion
triggers replicative senescence, a TP53 dependent cell cycle arrest, considered to provide a
tumour suppressive function [14, 15]. Superimposed on gradual telomere erosion are additional
mutational events that create short dysfunctional telomeres, in the absence of significant cell
division [16, 17]. If DNA damage checkpoints are defective, short telomeres may trigger geno-
mic instability, whereby the loss of the end-capping function leads to telomere-telomere fusion
events [18–21] and through anaphase-bridging-breakage fusion cycles generate large-scale rear-
rangements such as non-reciprocal translocations [22]. Telomere erosion and dysfunction is
observed in numerous tumour types including early-stage lesions [10, 23, 24] and the presence,
or absence, of telomeres within the length ranges at which fusion can occur is highly prognostic
[25, 26]. The development of Barrett’s oesophagus involves a hyper-proliferative and chronic
inflammatory state [27]; the associated cell turnover, as a consequence of exposure to reflux
acid and inflammatory mediated ROS induction, may drive telomere erosion and dysfunction.
Thus telomere dysfunction and fusion may provide one mechanism to create the genetic diver-
sity, upon which selection operates to drive clonal progression in conditions such as Barrett’s
oesophagus. Consistent with this, telomere erosion and chromosomal instability are early events
in the progression of Barrett’s oesophagus [28, 29] and is associated with LOH at 17p and 9p
[30]. Telomere erosion is specific to the epithelium compared with stromal cells [30] but it is
not related to levels of telomerase activity [28, 31]. Whilst telomere erosion has been docu-
mented previously in Barrett’s oesophagus, it has not clear if telomeres erode close to, or within,
the length ranges at which they can become dysfunctional, undergo fusion and hence drive
genomic instability. Here, by using high-resolution approaches to determine telomere length,
we have sought to examine the full extent of telomere erosion in Barrett’s oesophagus. In doing
so, we provide evidence of extreme telomere erosion and clonal evolution. These data are con-
sistent with the view that telomere dysfunction may contribute to the generation of clonal diver-
sity in Barrett’s oesophagus.
Results
The loss of loci on 17p (p53), 11q (cyclin D1) and 9p (p16) are known to be related to histologi-
cal progression in Barrett’s oesophagus [5, 6, 32], we considered that chromosome specific telo-
mere dynamics may drive the loss of loci on specific chromosome arms in Barrett’s oesophagus.
To investigate this we examined the telomere length distributions at the chromosome ends of
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17p, 11q and 9p, together with XpYp, a chromosome arm that has not been documented to suf-
fer copy-number changes in Barrett’s oesophagus. Analysis was undertaken using the highly
sensitive single telomere length analysis (STELA) technique, that is capable of determining the
telomere length of specific chromosome ends, and importantly can detect the very short telo-
meres that are capable of undergoing fusion; these telomeres are not represented in other telo-
mere-length assays [18, 19]. We analysed a small cohort of patients (n = 8) with Barrett’s
oesophagus, from which matched samples of gastric mucosae, Barrett’s metaplasia and squa-
mous epithelia had been obtained (Fig 1A and 1B). Despite considerable variation in telomere
length among individuals, each individual displayed similar patterns of the telomere length pro-
files in the tissues and at all four of the chromosome ends analysed (Fig 1A–1F). There was no
trend for any one telomere to be significantly shorter than any of the others (p = .51; Fig 1G). It
was clear from this analysis that the samples containing Barrett’s metaplasia, exhibited the
shortest telomere length profiles in 7 of the 8 individuals analysed (Highlighted in green, Fig
1C–1F). Interestingly however, it was also apparent that in 3 of the patients analysed, the Gastric
mucosa and Barrett’s metaplasia displayed indistinguishably short telomere length profiles
(Fig 1C–1F). Moreover, the telomere length profiles exhibited substantial heterogeneity,
with examples of apparent bimodal distributions observed in some samples, for example
patient #2 (Fig 1A); these profiles are consistent with a heterogeneous cellular composition
of the samples. Together these data indicate that no one specific telomere is likely to suffer
preferential telomere erosion in BE, and whilst Barrett’s metaplasia exhibits telomere ero-
sion, this can also be observed in normal gastric mucosae, with both showing shorter telo-
mere lengths than squamous oesophagus.
In order to examine in more detail the telomere length differentials between different tis-
sues and histological zones within the same tissues, we undertook an analysis of a second
cohort of Barrett’s oesophagus patients from which a systematic sampling of tissues at multiple
sites throughout both the normal and metaplastic regions of the oesophagus and stomach had
been undertaken [31]. Tissues biopsies were taken from normal squamous oesophageal epithe-
lium, the squamo-columnar junction (Z-line), Barrett’s metaplasia at 2 cm intervals, the oeso-
phago-gastric (O-G) junction, the gastric body and the gastric antrum, a total of 209 samples
were analysed from 24 patients. Given the within sample homogeneity of telomere length at
the four chromosomes analysed in the first cohort, telomere length analysis was undertaken at
just the 17p and XpYp telomeres (Fig 2). Comparing the overall means for all the tissue sites it
was clear that telomere length in normal squamous oesophageal epithelium was significantly
longer than all the other tissues analysed at both chromosome ends (p> .0001; Fig 3A and
3B). Interestingly this included the gastric tissues samples (O-G junction, Body and Antrum)
that displayed no significant difference in telomere length compared to those observed in Bar-
rett’s metaplasia (p = .11 and p = .064 for XpYp and 17p; Fig 3A and 3B).
The extent of telomere erosion detected in Barrett’s metaplasia samples was considerable
with 21% and 16% of samples exhibiting telomere erosion of over 2 kb compared the matched
normal samples at the 17p and XpYp telomeres respectively (Fig 3C and 3D). Moreover, 5% of
Barrett’s metaplasia samples, representing 4 of the 24 patients analysed (Fig 3A), exhibited
mean telomere lengths that were less than the 2.26 kb threshold that defines a poor prognosis
in both Chronic Lymphocytic Leukaemia and Breast Cancer [25, 26]. Strikingly, the telomere
erosion observed in Barrett’s metaplasia was not uniform; instead, more extensive erosion was
observed in patches at varying distances along the oesophagus (Fig 2), the telomere length
within these regions was also more homogenous, consistent with the telomere length profiles
observed in single cell clonal populations of primary fibroblast cell cultures [33], or in purified
tumour samples as observed in chronic lymphocytic leukaemia [23, 24]. Our observations are
consistent with a more extensive proliferative history, with localised clonal expansion within
Short telomeres in Barrett’s metaplasia
PLOS ONE | https://doi.org/10.1371/journal.pone.0174833 March 31, 2017 3 / 11
AXp
Yp 17
p
11
q 9p
0
2
4
6
8
10
Te
lo
m
er
e 
Le
ng
th
 (k
b)
B
G
0
5
10
15
20
X
pY
p 
 te
lo
m
er
e 
(k
b)
**** * *** **** ** **** **** **
#1 #2 #3 #4 #5 #6 #7 #8
0
5
10
15
20
17
p 
 te
lo
m
er
e 
(k
b)
* **** **** **** ** **** **** **
#1 #2 #3 #4 #5 #6 #7 #8
0
5
10
15
11
q 
 te
lo
m
er
e 
(k
b)
* **** *** *** **** ** ****
#1 #2 #3 #4 #5 #6 #7 #8
0
5
10
15
9p
  t
el
om
er
e 
(k
b)
*** **** **** *** **** * *******
#1 #2 #3 #4 #5 #6 #7 #8
C
D
E
F
Squamous Gastric Barrett’s
G SB
6.3 4.6 6.4
3.2 2.6 2.6
G SB
3.4 3.9 4.7
2.5 2.9 2.8
Mean (kb)
SD (kb)
0 kb-
1.6 kb-
4.6 kb-
8.6 kb-
0.6 kb-
17.1 kb-
X
pY
p 
te
l
le
ng
th
 (k
b)
#6#2
3.6 3.3 5.4
1.9 1.3 2.7
5.8 4.5 7.3
2.7 1.7 2.5
G SBG SB
0 kb-
1.6 kb-
4.6 kb-
8.6 kb-
0.6 kb-
17.1 kb-
17
p 
te
l
le
ng
th
 (k
b)
Mean (kb)
SD (kb)
#6#2
Fig 1. Shorter telomere length profiles are observed in Barrett’s metaplasia but no differences are
detected at four different chromosome ends. A, an example of STELA at the XpYp telomere in two patients
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zonal regions of Barrett’s metaplasia, which results in cells containing telomeres within the
length ranges at which telomere dysfunction and fusion has been detected.
Discussion
Our data show that, compared to normal patient-matched squamous epithelium, tissues exhib-
iting Barrett’s metaplasia display significantly shorter telomeres at all the chromosomes tested.
The extent of the difference was considerable with differences in mean telomere length of up
to 4.5 kb. If one considers the telomere length profiles of the normal squamous epithelium to
be representative of the progenitors from which the Barrett’s metaplasia was formed, then the
large telomere length differentials observed are consistent with an extensive replicative history.
The telomere dynamics and rates of erosion will be modulated by the replicative kinetics and
telomerase activities in these tissues, as well as genotoxic insults that may drive stochastic telo-
meric shortening. It will thus be difficult to use the telomere length differential between nor-
mal and Barrett’s metaplasia to precisely estimate the amount of cell division. However in the
absence of telomerase activity, assuming a telomere erosion rate of 85 bp/population doubling
as observed in normal telomerase negative human fibroblast populations [33], differences of
over 2kb between normal squamous epithelium and Barrett’s metaplasia would represent over
23 cell divisions. Clearly in the presence of telomerase that has been previously documented in
Barrett’s metaplasia [31], the rates of telomere erosion will be less and thus the telomere length
differentials will represent an even greater number of cell divisions. Moreover, the extent of
telomere erosion was not consistent throughout the Barrett’s metaplasia segments, instead we
observed distinct differences in both telomere length and the heterogeneity of the distributions
within the different zones analysed. Telomere length heterogeneity reflects the clonal composi-
tion of the tissue analysed, with more homogeneous distributions indicative of clonal cell pop-
ulations [33, 34]. Our data indicate that distinct clonal expansions can be observed at different
positions throughout the Barrett’s Oesophagus segments and that this varies between patients.
Taken together the observations of extensive telomere erosion and clonal expansion are con-
sistent with an extensive replicative history of cells during the development of Barrett’s meta-
plasia [35].
Our data also show no significant difference in telomere length between the Barrett’s meta-
plasia and the normal gastric tissues obtained from the OG-junction, the body and antrum.
The telomerase activity of these samples has been documented previously [31] and telomerase
activity was absent in the gastric tissues; body and antrum. Whereas, all the oesophageal
mucosa samples were telomerase-positive and this increased moving distally within the Bar-
rett’s mucosa [31]. Thus the short telomere length distributions observed in gastric tissues, is
consistent with on-going cell turnover in absence of sufficient telomerase activity. The pres-
ence of short telomeres, within the length ranges that are be capable of undergoing fusion,
may account for the high levels of aneuploidy that have previously been documented in nor-
mal gastric mucosa [36, 37]. However, caution should be applied to this interpretation, as
with matched normal squamous epithelium (S), Barrett’s metaplasia (B) and normal gastric mucosa (G). The
mean and standard deviation of telomere length profiles are detailed below. B, example of the same samples
analysed with STELA at the 17p telomere. C-F, telomere length profiles obtained from patients #1-#8, as
detailed above, depicted as scatter plots obtained by STELA at the telomeres of XpYp (C), 17p (D), 11q (E)
and 9p (F). Statistically significant differences between the Barrett’s metaplasia samples with either patient
matched squamous or gastric samples are illustrated with asterisks above the plots (two-tailed, Mann-
Whitney; * P 0.05, ** P 0.01, ***P 0.001 and ****P 0.0001), error bars represent 95% confidence
intervals. Patients in which the Barrett’s metaplasia sample displayed the shortest, or equal shortest, telomere-
length profiles are highlighted in green. G, scatter plot displaying the mean telomere lengths determined for
each chromosome end, error bars represent SD.
https://doi.org/10.1371/journal.pone.0174833.g001
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Fig 2. Telomere erosion in Barrett’s metaplasia occurs in zonal patches. A-B, examples of STELA of
multiple tissues as indicated above from separate two patients. Mean and standard deviation are detailed
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whilst the ‘normal’ tissues samples were histologically confirmed, they were derived from
patients with Barrett’s metaplasia and thus may not be entirely representative of these tissues
within the normal population.
Our data demonstrate that telomere erosion does not occur preferentially at specific chro-
mosome ends, with 9p, 11q, 17p and XpYp all displaying similar telomere length profiles.
Thus if telomere dysfunction is driving copy number changes at specific chromosome arms
then this is not related to the absolute length of the associated telomere. Instead this is more
consistent with a situation in which telomere erosion across all chromosome ends leads to the
accumulation of short dysfunctional telomeres that are capable of fusion and driving genome-
wide copy number changes and selection for specific chromosomal rearrangements [38].
below. C, scatterplot depicting STELA data from the XpYp (black) and 17p (green) telomeres from multiple
tissues derived from the same patient.
https://doi.org/10.1371/journal.pone.0174833.g002
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Fig 3. Extensive telomere erosion in Barrett’s metaplasia is similar to that observed in normal gastric tissues.
A, mean telomere lengths at the XpYp telomere from the tissues indicated below. The purple dashed line represents
the 2.2b kb threshold for prognosis defined in other tumour types [25]. B, mean telomere lengths at the 17p telomere
from the tissues indicated below. C-D, scatter plot displaying the difference between Barrett’s metaplasia samples and
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https://doi.org/10.1371/journal.pone.0174833.g003
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Whilst patient matched genomic data from Barrett’s metaplasia and oesophageal adenocarci-
noma indicated a comparatively low level of copy number changes in Barrett’s metaplasia,
there was a clear increase in copy number changes within adenocarcinomas [39]; these types
of genomic mutation may be consistent with telomere dysfunction during the transition from
Barrett’s metaplasia to oesophageal carcinoma. We have previously defined the telomere
length ranges in which telomere fusion can be detected in the B-cell clones of patients with
Chronic Lymphocytic Leukaemia (CLL). Stratification of both CLL and breast cancer patients
based on these thresholds provides definitive independent prognostic information for overall
survival [25, 26]. We detected telomere lengths in Barrett’s metaplasia samples within the same
length ranges defined in CLL. Mutations within key proteins required for a functional cell
cycle checkpoint including p16, p53 and over-expression of cyclin D1 [40–44] are commonly
detected in Barrett’s Metaplasia. It is thus tempting to speculate if, in the context of compro-
mised cell cycle checkpoint control, whether telomere-driven genome instability may play a
role in driving the progression of patients with Barrett’s Oesophagus.
Materials and methods
Sample collections and preparation
Tissue biopsies were obtained from 8 patients undergoing periodic endoscopy at Morriston
hospital in Swansea; the tissue samples were composed of gastric mucosae, Barrett’s metaplasia
and squamous epithelia. Ethical approval for the collection of samples of Barrett’s oesophagus
from endoscopic procedures at Morriston Hospital Swansea, was obtained from the Dyfed
Powys local research ethics (LREC) committee prior to commencement of the study. Informed
consent was obtained from all patients donating fresh tissue.
A second set of tissue biopsies were obtained from 24 patients undergoing periodic endos-
copy for Barrett’s oesophagus at Glasgow Royal Infirmary under conditions of anonymity
[31], the study was approved by the Glasgow Royal Infirmary Research Ethics Committee and
patients gave written informed agreement to participate. The tissue samples were composed of
biopsies taken every 2cm from the normal squamous epithelium of the oesophagus, oesopha-
geal squamo-columnar junction (“Z line”); through Barrett’s metaplasia, gastric cardia or the
oesophago-gastric junction, then the gastric body and antrum. All tissue samples were snap
frozen in liquid nitrogen and banked at -80˚C. The frozen tissues were disrupted with a tis-
sueruptor homogeniser (Qiagen) in lysis buffer after which the genomic DNA was extracted
by standard proteinase K, RNase A and phenol/chloroform protocols [45]. High molecular
weight DNA was solubilised by digestion in NotI or EcoR1 buffer prior to quantification. The
DNA concentration was then estimated in triplicate using Hoechst 33258 fluorometry.
Single telomere length analysis (STELA)
STELA at the telomeres of XpYp, 17p and 11q was undertaken as described previously [33,
34]. In addition, STELA was also carried out at the telomere of 9p, using the oligonucleotide
primer 9p2 (5’-CAC ATT CCT CAT GTG CTT ACG-3’). Multiple PCR reactions (typically 6)
were carried out for each DNA sample as follows: 20sec at 94˚C, 30sec at 65˚C (XpYpE2 [33]),
59˚C (17pseq1rev, [34]), 61˚C (9p2), and 66˚C (11q13B) [34] and 8 minutes at 68˚C for 22
(XpYpE2& 17pseq1rev) or 24 (9p2 & 11q13B) cycles. Amplified products were resolved by
0.5% agarose Tris-acetate–EDTA gel electrophoresis and detected by Southern hybridisation
with 33P-labelled TTAGGG repeat containing probes. This process typically results in 6–10
detectable telomeric molecules in each STELA reaction, however both the concentration and
quality of the DNA preparation will affect the dilution and single-molecule amplification effi-
ciency resulting in variable number of amplifiable molecules between samples.
Short telomeres in Barrett’s metaplasia
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